Cortexin vs Retinalamin
Comparison of Cortexin (Moderate evidence) and Retinalamin (Moderate evidence).
Last updated: February 12, 2026
Cortexin
Retinalamin
Overview
Cortexin and Retinalamin are both studied in the peptide research space.
Cortexin: A Russian neuropeptide complex derived from porcine or bovine cerebral cortex, approved in Russia and CIS countries for neurological conditions.
Retinalamin: A peptide complex extracted from bovine or porcine retinal tissue, developed by Russian scientist Vladimir Khavinson for ophthalmologic applications.
Evidence Comparison
| Aspect | Cortexin | Retinalamin |
|---|---|---|
| Evidence Level | Moderate | Moderate |
| Human Studies | 12 | 8 |
| Preclinical Studies | 16 | 8 |
| Total Sources | 28 | 18 |
Key Differences
| Aspect | Cortexin | Retinalamin |
|---|---|---|
| Category | Cognitive | Other |
| Evidence Strength | Moderate | Moderate |
| Total Sources | 28 | 18 |
| Human Studies | 12 | 8 |
Summary
- Cortexin: Moderate evidence with 28 total sources (12 human)
- Retinalamin: Moderate evidence with 18 total sources (8 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.